For citations:
Sigin V.O., Kuznetsova E.B., Simonova O.A., Zhevlova A.I., Litviakov N.V., Slonimskaya E.M., Tsyganov M.M., Volodin I.V., Shikeeva A.A., Strelnikov V.V., Zaletaev D.V., Tanas A.S. Medical DNA technology for evaluating the sensitivity of luminal B breast tumors to neoadjuvant anthracycline chemotherapy based on DNA methylation markers. Medical Genetics. 2017;16(10):29-35. (In Russ.)
Email this article 